Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Are PPIs created equal?

Executive Summary

Consumer Reports Best Buy Drugs recommends Procter & Gamble's Prilosec OTC, primarily due to cost advantages with the OTC proton pump inhibitor. The latest report compares Prilosec and Prilosec OTC, AstraZeneca's Nexium, TAP's Prevacid, Schering-Plough/Santarus' combination Zegerid, Wyeth's Protonix and Johnson & Johnson/Eisai's Aciphex and concludes that the drugs "are roughly equal in effectiveness and safety, but differ in cost." The report also suggests that claims by AstraZeneca that Nexium is the best drug for people with GERD and esophagitis are "marginal at best." AstraZeneca responds that Nexium controls stomach acid production better than any brand PPI and that the blockbuster PPI is clinically proven to heal damage to the esophagus, which Prilosec OTC has not demonstrated...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel